| Prescription drug use during pregnancy in developed countries: a systematic review JR Daw, GE Hanley, DL Greyson, SG Morgan Pharmacoepidemiology and drug safety 20 (9), 895-902, 2011 | 332 | 2011 |
| Matching and regression to the mean in difference‐in‐differences analysis JR Daw, LA Hatfield Health services research 53 (6), 4138-4156, 2018 | 263 | 2018 |
| Women in the United States experience high rates of coverage ‘churn’ in months before and after childbirth JR Daw, LA Hatfield, K Swartz, BD Sommers Health Affairs 36 (4), 598-606, 2017 | 192 | 2017 |
| Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010 JR Daw, SG Morgan Health Policy 104 (1), 19-26, 2012 | 140 | 2012 |
| Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001–2006) JR Daw, B Mintzes, MR Law, GE Hanley, SG Morgan Clinical therapeutics 34 (1), 239-249. e2, 2012 | 134 | 2012 |
| Estimated cost of universal public coverage of prescription drugs in Canada SG Morgan, M Law, JR Daw, L Abraham, D Martin CMAJ 187 (7), 491-497, 2015 | 116 | 2015 |
| Medicaid Expansion Improved Perinatal Insurance Continuity For Low-Income Women JR Daw, TNA Winkelman, VK Dalton, KB Kozhimannil, LK Admon Health affairs 39 (9), 1531-1539, 2020 | 78 | 2020 |
| Racial and ethnic disparities in perinatal insurance coverage JR Daw, GE Kolenic, VK Dalton, K Zivin, T Winkelman, KB Kozhimannil, ... Obstetrics & Gynecology 135 (4), 917-924, 2020 | 74 | 2020 |
| The Affordable Care Act and access to care for reproductive-aged and pregnant women in the United States, 2010–2016 JR Daw, BD Sommers American journal of public health 109 (4), 565-571, 2019 | 67 | 2019 |
| Association of the Affordable Care Act dependent coverage provision with prenatal care use and birth outcomes JR Daw, BD Sommers Jama 319 (6), 579-587, 2018 | 65 | 2018 |
| The ACA Medicaid Expansion And Perinatal Insurance, Health Care Use, And Health Outcomes: A Systematic Review M Bellerose, L Collin, JR Daw Health Affairs 41 (1), 60-68, 2022 | 59 | 2022 |
| Rethinking Pharmacare in Canada SG Morgan, JR Daw, MR Law CD Howe Institute, 2013 | 56 | 2013 |
| Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis JH Puyat, JR Daw, CM Cunningham, MR Law, ST Wong, DL Greyson, ... Social psychiatry and psychiatric epidemiology 48, 1861-1872, 2013 | 52 | 2013 |
| International best practices for negotiating ‘reimbursement contracts’ with price rebates from pharmaceutical companies S Morgan, J Daw, P Thomson Health Affairs 32 (4), 771-777, 2013 | 46 | 2013 |
| Association of Medicaid expansion with coverage and access to care for pregnant women MA Clapp, KE James, AJ Kaimal, BD Sommers, JR Daw Obstetrics & Gynecology 134 (5), 1066-1074, 2019 | 45 | 2019 |
| Matching in difference‐in‐differences: between a rock and a hard place JR Daw, LA Hatfield Health services research 53 (6), 4111, 2018 | 43 | 2018 |
| High Rates Of Perinatal Insurance Churn Persist After The ACA JR Daw, KB Kozhimanni, LA Admon Health Affairs Blog, 2019 | 41 | 2019 |
| Canadian pharmacare: looking back, looking forward SG Morgan, JR Daw Healthcare Policy 8 (1), 14, 2012 | 40 | 2012 |
| Growth in private payments for health care by Canadian households MR Law, JR Daw, L Cheng, SG Morgan Health Policy 110 (2-3), 141-146, 2013 | 39 | 2013 |
| Here today, gone tomorrow: the issue attention cycle and national print media coverage of prescription drug financing in Canada JR Daw, SG Morgan, PA Thomson, MR Law Health policy 110 (1), 67-75, 2013 | 39 | 2013 |
Steve MorganProfessor of health policy, University of British Columbia在 ubc.ca 的电子邮件经过验证
